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arresting pit-and-fissure occlusal
caries in primary and permanent molars
A systematic review of randomized controlled
trials—a report of the American Dental Association
and the American Academy of Pediatric DentistryABSTRACT
Background. NationalHealth andNutrition Examination Survey 2011-2012 data
indicated that, in the United States, nearly one-fourth of children and over one-half
of adolescents experienced dental caries in their permanent teeth. The purpose of
this review was to summarize the available clinical evidence regarding the effect of
dental sealants for the prevention and management of pit-and-fissure occlusal
carious lesions in primary and permanent molars, compared with a control without
sealants, with fluoride varnishes, or with other head-to head comparisons.
Type of Studies Reviewed. The authors included parallel and split-mouth
randomized controlled trials that included at least 2 years of follow-up, which they
identified using MEDLINE (via PubMed), Embase, LILACS, the Cochrane Central
Register of Controlled Trials, and registers of ongoing trials. Pairs of reviewers
independently conducted the selection of studies, data extraction, risk of bias as-John T. Wright, DDS, MS; Malavika P.
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Labra, DDS, MSc, PhD(c)sessments, and quality of the evidence assessments by using the Grading of Rec-
ommendations Assessment, Development and Evaluation approach.
Results. Of 2,869 records screened, the authors determined that 24 articles
(representing 23 studies) proved eligible. Moderate-quality evidence suggested that
participants who received sealants had a reduced risk of developing carious lesions
in occlusal surfaces of permanent molars compared with those who did not receive
sealants (odds ratio [OR], 0.15; 95% confidence interval [CI], 0.08-0.27) after 7 or
more years of follow-up. When the authors compared studies whose investigators
had compared sealants with fluoride varnishes, they found that sealants reduced the
incidence of carious lesions after 7 or more years of follow-up (OR, 0.19; 95% CI,C aries prevalence hasdeclined in developedcountries over the pastseveral decades; however,
many populations within these
nations still carry a large burden
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0.07-0.51); however, this finding was supported by low-quality evidence. On the
basis of the evidence, the authors could not provide a hierarchy of effectiveness
among the studies whose investigators had conducted head-to-head comparisons.
The investigators of 2 trials provided information about adverse events, but they did
not report any adverse events.
Conclusions and Practical Implications. Available evidence suggests that
sealants are effective and safe to prevent or arrest the progression of noncavitated2011-2012 data indicated that, in the
United States, nearly one-fourth
of children and over one-half ofe is
nt.
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carious lesions compared with a control without sealants or fluoride varnishes.
Further research is needed to provide information about the relative merits of the
different types of sealant materials.
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caries arrest; pit-and-fissure sealants; systematic review.
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ABBREVIATION KEY. GI: Glass ionomer. GRADE:
Grading of Recommendations Assessment, Development and
Evaluation. PFM: Permanent first molar. PM: Permanent
molar. RCT: Randomized controlled trial.
ORIGINAL CONTRIBUTIONSadolescents experienced dental carious lesions in their
permanent teeth.2 Occlusal surfaces, especially those on
permanent molars, contain grooves called pits and fis-
sures that can trap debris and microorganisms, thereby
increasing the risk of developing dental carious lesions.
Indeed, the caries that are found in the adolescent pop-
ulation are represented disproportionately in the pits and
fissures of teeth compared with the smooth surfaces.3
Fluorides and other caries preventive approaches (for
example, mechanical plaque control) seem to be less
effective for preventing carious lesions in pit-and-fissure
surfaces compared with smooth surfaces.3 Pit-and-fissure
sealants, or simply sealants, were developed to help
manage these sites of dental stagnation that are resistant
to other therapeutic approaches and contribute to a
significant portion of caries disease burden in the pop-
ulation. Sealants are an underused therapy; only 30% of
children 6 to 8 years old have at least 1 dental sealant.4
Sealants are dental materials that dentists apply to the
pit-and-fissure surfaces of teeth. The sealant material
penetrates pits and fissures and then hardens, acting as a
physical barrier that stops or inhibits the ingress of
bacteria and nutrients. Researchers conducted the first
clinical trials in the late 1960s and early 1970s using a
variety of materials. Today there are multiple commer-
cially available sealant materials, including resin-based
sealants such as urethane dimethacrylate or bisphenol
A-glycidyl methacrylate monomers that are polymerized
by means of either a chemical activation-initiation or a
light activation system. Glass ionomer (GI) cements are
another type of sealant material that have been widely
recognized and used for their fluoride-release properties,
which stem from the acid-base reaction between a fluo-
roaluminosilicate glass powder and an aqueous-based
polyacrylic acid solution. Polyacid-modified resin seal-
ants, also referred to as compomers, combine resin-based
material found in traditional resin-based sealants with
the fluoride-release and adhesive properties of GI seal-
ants. Resin-modified GI sealants are essentially GI
sealants with resin components that allow for light
polymerization.5 These dental materials differ in many
of their physical properties, including hydrophobicity,
fracture resistance, thermal expansion, and bond
strength. Also, investigators have found that topical
fluoride varnishes (sodium fluoride) substantially
prevent dental caries in children and adolescents by
decreasing demineralization, promoting remineraliza-
tion, and possibly inhibiting the effects of bacterial
biofilm.6
Investigators have conducted a number of systematic
reviews to determine the clinical effectiveness, cost-
effectiveness, and safety of pit-and-fissure sealants
compared with another type of sealant material, a control
without sealants, and fluoride varnishes. The authors of 1
review reported that sealants were effective in preventing
occlusal and proximal carious lesions in the molars of632 JADA 147(8) http://jada.ada.org August 2016children when compared with controls without sealants.7
The authors of this review also reported inconclusive and
inconsistent results related to the potential superiority of
any of the sealant materials in head-to-head compari-
sons.7 The authors of another systematic review sug-
gested that sealants may be more effective than fluoride
varnishes in preventing occlusal carious lesions in molars
in children, but the quality of the evidence was low.6
The investigators of both of these systematic reviews6,7
reported that the authors of most of the included studies
did not mention adverse events, and even when authors
did mention adverse events, they did not report any
adverse events that had occurred in their studies.6,7
The purpose of this review was to summarize the
available evidence regarding the effect of dental sealants
for the prevention of pit-and-fissure occlusal caries in
primary and permanent molars on children, adolescents,
and adults compared with a control without sealants,
with fluoride varnishes, or with another head-to-head
comparison to inform the development of a joint
evidence-based clinical practice guideline by the
American Dental Association and the American
Academy of Pediatric Dentistry.8
METHODS
This report follows the guidance of the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses statement.9
Selection criteria for the studies in this review.
Type of studies. We included parallel and split-mouth
randomized controlled trials (RCTs) with at least 2 years
of follow-up. We excluded quasirandomized trials,
nonrandomized trials, and observational studies.
Type of participants. We included studies that
involved children, adolescents, and adults from the
general population who did or did not have a history
of carious lesions and who had either a sound occlusal
surface or a noncavitated carious lesion in primary and
permanent molars.
Type of interventions. For this systematic review,
we defined 4 categories of sealant materials: resin-based
sealants, GI cements or GI sealants, resin-modified GI
sealants, and polyacid-modified resins. We classified
resin-modified GI sealants as a subcategory of the GI
sealants category and polyacid-modified resins as a
subcategory of the resin-based sealants category.5
We defined “intervention” as any of the 4 types of
sealant materials described previously, irrespective of
the application technique. We excluded studies whose
investigators used sealant materials that were not
ORIGINAL CONTRIBUTIONScommercially available at the time of this review.
We defined “comparison” as any type of sealant material
irrespective of the application technique, the nonplace-
ment of sealants, or the use of fluoride varnishes.
Type of outcome measures. We defined “caries inci-
dence” as the identification of a new carious lesion on the
occlusal surface of a primary or permanent molar
that compromised dentin tissue. We defined “lack of
retention” as the complete detachment or retention loss
of the sealant material from the grooves and pits in the
occlusal surface of a tooth with no macroscopically
visible sealant material. We defined “adverse effects” as
any potential adverse effect defined by the authors of
the primary studies. For all outcomes, we grouped the
studies into 3 categories according to the length of
follow-up: 2 to 3 years, 4 to 7 years, and 7 or more years.
Search methods for the identification of studies.
Electronic databases. We searched MEDLINE (via
PubMed), Embase, LILACS, and the Cochrane Central
Register of Controlled Trials (CENTRAL) from January
1971 to May 2013. We searched MEDLINE (via PubMed)
and the Cochrane Central Register of Controlled Trials
(CENTRAL) from June 2013 to May 2016. We used a
combination of key words and controlled vocabulary that
we adapted for each electronic database. We used filters,
such as the Cochrane Highly Sensitive Search Strategy,
for identifying randomized trials (Appendix, available
online at the end of this article).10
Other type of resources. We searched ClinicalTrials.
gov to identify completed or ongoing RCTs that were not
yet published and indexed in the regular electronic indices.
We also screened the reference lists of included studies
fromprevious systematic reviews to ensure that we had not
omitted relevant studies. We did not exclude any studies
on the basis of the status or language of publication.
Data collection and analysis. Selection of studies. In
the first stage, 2 reviewers (M.T., L.G.) independently
screened the titles and abstracts of all retrieved references by
using a standardized form. Because they used an inclusive
criterion, when the reviewers disagreed on the eligibility
status for a particular reference, they included the citation
in question at this stage and resolved the disagreement at
the full-text screening stage. In the second stage, 2 reviewers
independently screened the full text of all potentially
eligible studies. They resolved any disagreement by means
of discussion.When consensus was elusive, a third reviewer
(C.E.), acting as an arbiter, decided final eligibility.
Data extraction and management. Using a stan-
dardized form, 2 reviewers (M.T., L.G.) independently
extracted data from all the included studies. The form
included instructions to extract the main characteristics
of the studies, including the type of study design (par-
allel, split-mouth), population (age, sex, selection criteria,
caries history, clinical diagnosis of the occlusal surface to
be sealed), type of sealant material and the comparison
(nonuse of sealant or an active comparator), and theoutcomes (specific definition from the primary study and
results). When these reviewers identified discrepancies
that they were unable to clarify, a third reviewer (C.E.)
acted as arbiter.
Assessment of the risk of bias of included studies. Two
reviewers (M.T., A.C.L.) independently conducted an
assessment of the risk of bias for each included study by
using the Cochrane risk of bias tool.11 We assessed the
following types of bias in each study: selection bias (Was
allocation randomized and concealed to ensure compara-
bility between groups?), detection bias (Were the patients
and outcome assessors unaware of which treatment was
applied?), attrition bias (Were dropout rates sufficiently
low to ensure that groups were still comparable at follow-
up?), reporting bias (Did investigators selectively report
outcomes?), and other sources of bias. For each domain,
we determined whether a study had a high, low, or unclear
risk of bias. We considered randomization sequence
generation and allocation concealment to be the most
important domains for the overall assessment of risk
of bias. We resolved any disagreements by means of
discussion until we reached consensus.
Measures of treatment effect and missing data. We
analyzed caries incidence, lack of retention, and adverse
events as dichotomous outcomes. For studies in which
the investigators reported sealants as being fully retained,
partially retained, and not retained, we grouped the fully
and partially retained events and compared them with
the sealants that were not retained to create the estimate.
We calculated odds ratios (OR) and 95% confidence
intervals (CI) for both outcomes. For each study, we
calculated the proportion of missing participant data,
and we determined to what extent the amount of missing
data was substantial enough to change the magnitude
and direction of the estimates to the point of dramati-
cally changing the conclusions, as suggested by Akl and
colleagues.12 Otherwise, we used complete case analysis.
Assessment of heterogeneity. We conducted the
assessment of heterogeneity by following the guidance
of the Cochrane Handbook for Systematic Reviews of
Intervention.13 We used the c2 test to determine the
presence of statistical heterogeneity, and we set the
level of significance at .1. In addition, we quantified the
amount of heterogeneity among studies using the I2
statistic, in which we considered a value of I2 40% or less
to be unimportant heterogeneity, a value of I2 from
30% through 60% to be moderate heterogeneity, a
value of I2 from 50% through 90% to be substantial
heterogeneity, and a value of I2 from 70% through 100%
to be considerable heterogeneity.
Assessment of publication bias. We conducted the
assessment of publication bias by following the recom-
mendations from the Cochrane Handbook for Systematic
Reviews of Intervention.14 If we noted that an outcome
was informed by more than 10 studies, then we explored
publication bias by using funnel plots.JADA 147(8) http://jada.ada.org August 2016 633
TABLE 1
Levels of quality of evidence (certainty
in the evidence).*
QUALITY
LEVEL
DEFINITION
High We are very confident that the true effect lies close to that
of the estimate of the effect
Moderate We are moderately confident in the effect estimate; the
true effect is likely to be close to the estimate of the
effect, but there is a possibility that it is substantially
different
Low Our confidence in the effect estimate is limited; the true
effect may be substantially different from the estimate of
the effect
Very Low We have very little confidence in the effect estimate; the
true effect is likely to be substantially different from the
estimate of effect
* Reproduced with permission of the publisher from Balshem and
colleagues.18
ORIGINAL CONTRIBUTIONSData synthesis. Investigators of RCTs who measured
the effectiveness of interventions to prevent carious le-
sions typically used 1 of 2 designs: split-mouth or parallel.
In RCTs whose investigators used a parallel design, the
investigators allocated study participants to receive either
the experimental treatment or a control. In split-mouth
trials, the investigators randomly assigned 1 of 2 treat-
ments (for example, sealant versus no sealant) to the
same type of tooth on the right and left sides of the
participant’s mouth. One advantage of conducting split-
mouth trials is that these types of RCTs minimize vari-
ability among study participants, as the intervention and
control teeth are in the same person’s mouth. One po-
tential issue, however, is that the preventive benefits of
the intervention may carry over to the control teeth. We
judged these carryover effects to be minimal for sealants,
and therefore, we pooled the findings from studies whose
investigators had used each of these designs to create a
single effect estimate by using the methodology proposed
by Lesaffre and colleagues15 and Elbourne and col-
leagues.16 We used Review Manager (RevMan), Version
5.3 (Cochrane Collaboration) to conduct the analysis. To
obtain the pooled estimate, we used the generic inverse-
variance method with a random-effects model. When we
included fewer than 4 studies in the meta-analysis, we
used a fixed-effects model.
Subgroup analysis. We conducted subgroup analysis
to determine whether the studies whose investigators had
enrolled participants with noncavitated pit-and-fissure
occlusal carious lesions, sound occlusal surfaces, and
those who had both (that is, a population who had a mix
of both sound occlusal surfaces and noncavitated carious
lesions) had different treatment effects. For the interac-
tion test, we used a level of significance of .05.
Assessment of the quality of the evidence. We
determined the quality of the evidence (certainty in the
estimates of effect) for each outcome by using the634 JADA 147(8) http://jada.ada.org August 2016Grading of Recommendations Assessment, Development
and Evaluation (GRADE) approach.17 With the GRADE
approach, RCTs start as high-quality evidence; however,
the quality or certainty in the body of evidence decreases
to moderate-, low-, or very low–quality evidence if
serious or very serious issues related to risk of bias,
imprecision, inconsistency, indirectness, and publication
bias are present (Table 1).18 Two reviewers (M.T., A.C.L.)
independently conducted these evaluations.
RESULTS
Results of the search. The search process resulted in
2,869 references, which we screened to assess their titles
and abstracts; we excluded 2,419 references at that stage
of the search process. Next, we excluded 426 articles,
which we had assessed by means of full-text screenings,
and we included 24 articles,1,19-41 which represented 23
studies, in this review (Figure 1).
Characteristics of included studies. We included 24
articles (representing 23 studies) published from 1976
through 2016,1,19-41 whose investigators had reported data
related to the effectiveness of sealants compared with a
control without sealants,1,19-26 fluoride varnishes,20,22,27
or other head-to-head comparisons.28-40 Nine studies’
investigators used a parallel design,20,22,24,26,28,31,33,38,39,41
whereas 14 studies’ investigators used a split-mouth
design.1,19,21,23,25,27,29,30,32,34-37,40 Table 2 summarizes the
characteristics of the included populations, which in-
vestigators described as including children and adoles-
cents aged 3 to 16 years who were living in settings with
and without water fluoridation. We did not identify any
studies that met the selection criteria whose investigators
had provided information about the effect of sealants
in an adult population.
Risk of bias of included studies. Poor quality of
reporting of the included studies prevented us from
conducting a complete assessment of the risk of bias. For
most of the studies, we assessed the key 3 domains of
random sequence generation, allocation concealment,
and masking of participants and personnel as having an
unclear risk of bias. Of these 3 domains, we determined
that allocation concealment was the most serious and
underreported methodological issue (Figure 2).
Effects of the interventions. Comparison 1. Sealants
versus nonuse of sealants. Caries incidence. The results
of 9 studies1,19-26 (3,542 participants) informed the com-
parison and outcome for the 2- to 3-year follow-up
category. In relative terms, participants who received
sealants reduced their risk of developing new carious
lesions by 76% (odds ratio [OR], 0.24; 95% confidence
interval [CI], 0.19-0.30; P < .00001) compared with
participants who did not receive sealants. The hetero-
geneity was moderate (c2 P ¼ .09; I2 ¼ 41%); however,
the investigators of all of the individual studies reported
the same direction of effect with an overlap of CIs
(eFigure 1, available online at the end of this article). In a
Records identified
through database
searching (n = 4,483)
Additional records
identified through
other sources (n = 487)
Records
screened
(n = 2,869)
Duplicates and
non-English
publications excluded
(n = 2,101)
Records
excluded
(n = 2,419)
Full-text articles
assessed for
eligibility
(n = 450)
Full-text
articles
excluded
(n = 426)
Studies included in the
quantitative synthesis
(meta-analysis)
(n = 22 [23 articles])
Studies included in the
qualitative synthesis (n = 1)
Figure 1. Flowchart of the screening and study selection process.
ORIGINAL CONTRIBUTIONSsubgroup analysis conducted to determine whether the
treatment effect differed among studies with patients
who had noncavitated occlusal carious lesions, sound
occlusal surfaces, and a population with mixed features,
we did not find statistically significant results (interaction
test P ¼ .58). We assessed the quality of the evidence for
this outcome as moderate, owing to serious issues related
to risk of bias (Table 3).
The results of 3 studies20,21,23 (752 participants)
informed the comparison and outcome for the 4- to
7-year follow-up category. In relative terms, participants
who received sealants had a reduction in the risk of
developing new carious lesions by 79% (OR, 0.21; 95% CI,
0.10-0.44; P < .0001) compared with participants who
did not receive sealants (eFigure 2, available online at the
end of this article). Because the investigators of all 3 of
these studies included only participants with sound
occlusal surfaces, we did not perform a subgroup anal-
ysis. Serious issues of inconsistency (c2 P ¼ .01; I2 ¼
77%) and risk of bias warranted us to determine that low-
quality evidence informed this outcome (Table 3).
The results of 2 studies20,23 (446 participants)
informed the comparison and outcome for the 7 or more
years of follow-up category. In relative terms, partici-
pants who received sealants had a reduction in the risk of
developing new carious lesions by 85% (OR, 0.15; 95% CI,
0.08-0.27; P < .00001) compared with participants who
did not receive sealants (eFigure 3, available online at the
end of this article). The heterogeneity was moderate to
high (c2 P ¼ .16; I2 ¼ 50%); however, the investigators of
all of the individual studies found the same direction of
effect with an overlap of CIs. Because the investigators
of the 2 studies included only participants with sound
occlusal surfaces, we did not perform a subgroup anal-
ysis. We assessed the quality of the evidence for this
outcome as moderate, owing to serious issues related to
risk of bias (Table 3).
Lack of retention. The nature of the comparison did
not allow us to obtain information to compare the use
versus the nonuse of sealants.
Comparison 2. Sealants versus fluoride varnishes.
Caries incidence. The results of 3 studies20,22,27 (1,715
participants) informed the comparison and outcome for
the 2- to 3-year follow-up category. In relative terms,
participants who received sealants had a 73% reduction
in the risk of developing new carious lesions (OR, 0.27;
95% CI, 0.11-0.69; P ¼ .006) compared with participants
who received fluoride varnishes (eFigure 4, available
online at the end of this article). In a subgroup analysis
conducted to determine whether the treatment effect
differed among studies with patients having noncavitated
occlusal carious lesions, sound occlusal surfaces, and a
population with mixed features, we found statistically
significant results (interaction test P ¼ .04); however, this
subgroup analysis did not explain the heterogeneity of
the results. The investigators of both subgroups of studieswith sound occlusal surfaces (OR, 0.19; 95% CI, 0.07-0.47;
P ¼ .0004) and with a mixed population of participants
with and without noncavitated carious lesions (OR, 0.66;
95% CI, 0.30-1.44; P ¼ .3) found that there was a bene-
ficial effect when using sealants; however, this difference
was not statistically significant in the latter study.22 We
assessed the quality of the evidence for this outcome as
low, owing to serious issues related to inconsistency (c2
P ¼ .002; I2 ¼ 88%) and risk of bias (eTable 1, available
online at the end of this article).
The results of 2 studies20,27 (472 participants) informed
the comparison and outcome for the 4- to 7-year follow-
up category. In relative terms, participants who received
sealants had an 81% reduction in the risk of developing
new carious lesions (OR, 0.19; 95% CI, 0.07-0.51; P ¼
.0008) compared with participants who received fluoride
varnishes (eFigure 5, available online at the end of this
article). Because the investigators of the 2 studies included
only participants with sound occlusal surfaces, we did not
perform a subgroup analysis. We assessed the quality of
the evidence for this outcome as low, owing to serious
issues of inconsistency (c2 P ¼ .03; I2 ¼ 80%) and risk of
bias (eTable 1, available online at the end of this article).JADA 147(8) http://jada.ada.org August 2016 635
TABLE 2
Characteristics of the included studies.
STUDY COUNTRY DESIGN PARTICIPANTS AGE RANGE,
Y (MEAN)
Bojanini and Colleagues,19
1976
Colombia Split-mouth Children with erupted, sound PM†; setting was not clearly defined 6-8
Richardson and Colleagues,25
1980
Canada Split-mouth Children with erupted, sound or carious PFM‡; setting was
an elementary school clinic
7-8
Houpt and Shey,27 1983 United
States
Split-mouth Children with erupted, sound PFM; setting was a dental van
(mobile unit)
6-10
Mertz-Fairhurst and Colleagues,23
1984
United
States
Split-mouth Children with erupted, sound PFM; setting was a dental school
clinic
6-8
Erdogan and Alacam,21 1987 Turkey Split-mouth Children with erupted, sound PFM; setting was not described 8-10
Arrow and Riordan,30 1995 Australia Split-mouth Children with sound PFM; setting was a school clinic 7 (0.72)
Bravo and Colleagues,20 1996 Spain Parallel Children with erupted, sound PM; setting was a school clinic 6-8
Splieth and Colleagues,1 2001 Germany Split-mouth Children with erupted, sound or carious PFM; setting was a
private practice office
5-8
Pereira and Colleagues,24 2003 Brazil Parallel Children with erupted, sound PFM; setting was a dental school
clinic
6-8
Gungor and Colleagues,37 2004 Turkey Split-mouth Children with erupted PFM; setting was a dental school clinic 7-10
Pardi and Colleagues,38 2005 Brazil Parallel Children with erupted PFM; setting was a school clinic 7-8
Ganesh and Tandon,40 2006 India Split-mouth Children with erupted, sound primary molars (Group 1)
and erupted, sound permanent molars (Group 2)
Group 1: 3-5
Group 2: 6-7
Amin,28 2008 Egypt Parallel Children with sound PFM; setting was a dental school clinic 7-10
Barja-Fidalgo and Colleagues,31
2009
Brazil Parallel Children with erupted PFM; setting was a university dental clinic 6-8
Baseggio and Colleagues,32 2010 Brazil Split-mouth Adolescents with erupted second PM; setting was a public
health service center
12-16
Tagliaferro and Colleagues,26
2011
Brazil Parallel Children with erupted, sound PFM; setting was a private practice 6-8
Antonson and Colleagues,29 2012 United
States
Split-mouth Children with partially erupted PFM; setting not clearly defined,
seems to be a university dental clinic
5-9
Chen and Colleagues,33,41 2012
(2 reports)
China Parallel Children with erupted, carious PFM; setting was at 5 public
schools
7-9.1
Dhar and Chen,35 2012 India Split-mouth Children with erupted PFM; setting was a school clinic 6-10
Liu and Colleagues,22 2012 China Parallel Children with erupted, sound or carious PFM; setting was
a school clinic
Mean ¼ 9.1
Chen and Liu,34 2013 China Split-mouth Children with erupted, sound PFM; setting was a pediatric
department of a university hospital
6.1-8.9
Guler and Yilmaz,36 2013 Turkey Split-mouth Children with erupted PFM; setting was a dental school clinic 7-13
Haznedaroglu and Colleagues,39
2016
Turkey Parallel Children with fully erupted, sound PFMs; setting was a
university pediatric clinic
7-10
* Information provided corresponds with the first follow-up period of the study.
† PM: Permanent molar.
‡ PFM: Permanent first molar.
§ GI: Glass ionomer.
¶ ppm: Parts per million.
ORIGINAL CONTRIBUTIONS
636 JADA 147(8) http://jada.ada.org August 2016
TABLE 2 (CONTINUED)
FLUORIDE EXPOSURE INTERVENTION COMPARISON SEALANT
(N)*
COMPARISON
(N)*
Community water fluoridation Resin-based sealant (Delton,
Dentsply)
No sealant 42 42
Nonfluoridated community Self-curing bisphenolA-glycidyl
methacrylate sealant (3M)
No sealant 337 337
Community water fluoridation Sealant (Delton, Dentsply) Fluoride varnish (no further
description)
250 250
Community water fluoridation Resin-based sealant (Delton,
Dentsply)
No sealant 201 201
None Resin-based sealant (Delton,
Dentsply)
No sealant 96 96
None GI§ sealant (Ketac-fil, 3M) Resin-based sealant (Delton,
Dentsply)
412 412
Community water fluoridation at 0.07 ppm¶
of fluoride
Resin-based sealant (Delton,
Dentsply)
No sealant; fluoride varnish
(Duraphat, Colgate-Palmolive)
238 272
Community water fluoridation at 0.1 ppm. Fluoride
tablets used for first year of their life only (48%), and
some children took tablets during study (5%).
Duraphat fluoride varnishwas applied in both groups.
Resin-based sealant No sealant 176 176
Community water fluoridation Sealant
GI sealant (Ketac bond, 3M)
No sealant;
resin-modified GI sealant
(Vitremer, 3M)
342 240
Nonfluoridated water; encouraged use of
fluoridated toothpaste
Poly-acid modified resin
(Dyract Seal, Dentsply)
Resin-based sealant (Delton FSþ,
Dentsply)
70 70
Community water fluoridation Resin-modified GI sealant
(Vitremer, 3M)
Resin-based sealant (Revolution,
Kerr);
poly-acid modified resin sealant
(Dyract Flow, Dentsply)
97 182
None GI sealant (Fuji VII, GC) Resin-based sealant (Concise, 3M) 100 100
Fluoridated toothpaste Resin-modified GI sealant
(Fuji II LC, GC)
Resin-based sealant (Tetric Flow
and Helioseal F, Ivoclor Vivadent)
24 54
Fluoridated toothpaste GI sealant (Fuji IX, GC) Resin-based sealant (Delton,
Dentsply)
21 28
None Resin-modified GI sealant
(Vitremer, 3M)
Resin-based sealant
(Fluoroshield, Dentsply)
628 628
Community water fluoridation at 0.7 ppm, and 93%
of participants reported using fluoridated toothpaste
Resin-modified
GI sealant (Vitremer, 3M)
No sealant 91 86
None GI sealant (Fuji Triage, GC) Resin-based sealant (Delton FSþ,
Dentsply)
27 27
None GI sealant (Ketac Molar
Easymix, 3M)
Resin-based sealant (Clinpro,
3M)
1,282 452
None GI sealant (Fuji VII, GC) Resin-based sealant (Clinpro, 3M) 50 50
No community water fluoridation, but 90% of
toothpastes sold in area contain fluoride
Resin-based sealant (Clinpro,
3M)
No sealant; fluoride varnish (5%
sodium fluoride Duraphat,
Colgate-Palmolive)
367 379
Use of 600 ppm fluoridated toothpaste.
6,000 ppm foam applied at every recall visit
GI sealant (Fuji VII, GC) Resin-based sealant (Concise,
3M)
75 75
Fluoride varnish applied after sealant placement GI sealant (Fuji VII, GC) Resin-based sealant (Admira
Seal, Voco)
68 66
“Low fluoride” in drinking water GI sealant (Fuji Triage, GC) Resin-based sealant (Ultraseal XT,
Ultradent)
64 68
ORIGINAL CONTRIBUTIONSThe results of 1 study20 (242 participants) informed the
comparison and outcome for the 7 ormore years of follow-
up category. In relative terms, participants who received
sealants had a 71% reduction in the risk of developing new
carious lesions (OR, 0.29; 95% CI, 0.17-0.49; P < .00001)
compared with participants who received fluoridevarnishes (eFigure 6, available online at the end of this
article). Because the results of only 1 study informed this
outcome, we did not perform a subgroup analysis. We
assessed the quality of the evidence for this outcome as
low, owing to very serious issues related to risk of bias
(eTable 1, available online at the end of this article).JADA 147(8) http://jada.ada.org August 2016 637
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Amin,28 2008 ? ? ? – + + ?
Antonson and Colleagues,29 2012 + ? ? + + + ?
Arrow and Riordan,30 1995 – ? ? ? + + ?
Barja-Fidalgo and Colleagues,31 2009 + + ? + + + +
Baseggio and Colleagues,32 2010 – + ? ? + + ?
Bojanini and Colleagues,19 1976 + ? ? ? + + +
Bravo and Colleagues,20 1996 + ? ? ? ? + ?
Chen and Colleagues,33,41 2012 + + ? ? + + ?
Chen and Liu,34 2013 + ? ? + + + +
Dhar and Chen,35 2012 + ? ? + + + ?
Erdogan and Alacam,21 1987 ? ? ? ? + + +
Ganesh and Tandon,40 2006 ? ? – ? + + +
Guler and Yilmaz,36 2013 ? ? ? ? + + ?
Gungor and Colleagues,37 2004 + ? + + + + ?
Haznedaroglu and Colleagues,39 2016 + + + – – + ?
Houpt and Shey,27 1983 ? ? ? + – + ?
Liu and Colleagues,22 2012 + ? ? + + + +
Mertz-Fairhurst and Colleagues,23 1984 ? ? – ? + + ?
Pardi and Colleagues,38 2005 ? ? ? ? + + ?
Pereira and Colleagues,24 2003 ? ? ? + + + ?
Richardson and Colleagues,25 1980 + ? ? – + + ?
Splieth and Colleagues,1 2001 ? ? ? – + ? ?
Tagliaferro and Colleagues,26 2011 ? ? ? + + + +
ST
U
D
IE
S
DOMAIN
Figure 2. Risk of bias summary: review authors’ judgments about each risk of bias item for each included study.
þ: Low risk of bias. : High risk of bias. ?: Unclear risk of bias.
ORIGINAL CONTRIBUTIONS
638 JADA 147(8) http://jada.ada.org August 2016Lack of retention. The
nature of the comparison
did not allow us to
obtain information to
compare the use versus
the nonuse of sealants.
Comparison 3.
Glass ionomer sealants
versus resin-based seal-
ants. Caries incidence.
The results of 10
studies28-30,32-36,38,39 (4,741
participants) informed
the comparison and
outcome for the 2- to 3-
year follow-up category.
In relative terms, partic-
ipants who received GI
sealants had a 29%
reduction in the risk of
developing new carious
lesions compared with
participants who
received resin-based
sealants (OR, 0.71; 95%
CI, 0.32-1.57); however,
this difference was not
statistically significant
(P ¼ .39) (eFigure 7,
available online at the
end of this article).
Owing to limitations in 1
study’s40 data presenta-
tion, we did not include
that study (200 partici-
pants) in the meta-
analysis. For that study,40
the investigators failed
to find a clinically or
statistically significant
difference in caries inci-
dence when they applied
GI sealants and resin-
based sealants in the
occlusal surfaces of pri-
mary and permanent
molars. In a subgroup
analysis conducted to
determine whether the
treatment effect differed
among studies with
patients having non-
cavitated occlusal carious
lesions, sound occlusal
surfaces, and a popula-
tion with mixed clinical
ORIGINAL CONTRIBUTIONSfeatures, we did not find statistically significant results
(interaction test P ¼ .19). We assessed the quality of the
evidence for this outcome as very low, owing to serious
issues related to risk of bias, inconsistency (c2 P >
.00001; I2 ¼ 81%), and imprecision (Table 4).
The results of 2 studies31,39 (145 participants) informed
the comparison and outcome for the 4- to 7-year follow-
up category. In relative terms, participants who received
GI sealants had a 63% reduction in the risk of developing
new carious lesions compared with participants who
received resin-based sealants (OR, 0.37; 95% CI, 0.14-1.00;
P ¼ .05) (eFigure 8, available online at the end of this
article). Because we found only 2 studies to inform this
outcome, we did not perform a subgroup analysis. We
assessed the quality of the evidence for this outcome as
very low, owing to serious issues related to risk of bias
and very serious issues related to imprecision (Table 4).
We did not find any studies whose investigators had
reported data on the incidence of caries for 7 or more
years of follow-up for this comparison.
Lack of retention. The results of 10 studies28-30,32-36,38,39
(4,741 participants) informed the comparison and
outcome for the 2- to 3-year follow-up category. In
relative terms, participants who received GI sealants had
5 times greater chance (406% increased chance) of
experiencing sealant retention loss compared with par-
ticipants who received resin-based sealants (OR, 5.06;
95% CI, 1.81-14.13; P ¼ .002) (eFigure 9, available online at
the end of this article). In a subgroup analysis conducted
to determine whether the treatment effect differed
among studies with patients who had noncavitated
occlusal carious lesions, sound occlusal surfaces, and a
population with mixed clinical features, we did not find
statistically significant results (interaction test P ¼ .29).
We assessed the quality of the evidence for this outcome
as low, owing to serious issues related to risk of bias and
inconsistency (c2 P < .00001; I2 ¼ 96%) (Table 4).
The results of 2 studies31,39 (145 participants) informed
the comparison and outcome for the 4- to 7-year follow-up
category. In relative terms, participants who received GI
sealants had a 108% increase in the risk of experiencing a
retention loss comparedwith the participants who received
resin-based sealants (OR, 2.08; 95%CI,0.15-27.95); however,
this difference was not statistically significant (P ¼ .58)
(eFigure 10, available online at the end of this article).
Because only 2 studies informed this outcome, we did not
perform a subgroup analysis.We assessed the quality of the
evidence for this outcome as low, owing to serious issues
related to risk of bias and imprecision (Table 4).
We did not find any studies whose investigators had
reported data on the incidence of lack of sealant reten-
tion for 7 or more years of follow-up.
Comparison 4. Glass ionomer sealants versus resin-
modified glass ionomer sealants. Caries incidence. The
results of 1 study24 (344 participants) informed the
comparison and outcome for the 2- to 3-year follow-upcategory. In relative terms, participants who received GI
sealants had a 41% increased risk of developing new
carious lesions compared with participants who received
resin-modified GI sealants (OR, 1.41; 95% CI, 0.65-3.07)
(eFigure 11, available online at the end of this article);
however, this difference was not statistically significant
(P ¼ .38). Because only 1 study informed this outcome,
we did not perform a subgroup analysis. We assessed the
quality of the evidence for this outcome as very low,
owing to serious issues related to risk of bias and very
serious issues related to imprecision (eTable 2, available
online at the end of this article).
We did not find any studies whose investigators had
reported data on caries incidence for the 4- to 7-year
follow-up category and the more than 7 years of follow-
up category.
Lack of retention. The results of 1 study24 (344 partici-
pants) informed this comparison and outcome for the 2- to
3-year follow-up category. In relative terms, participants
who received GI sealants had 3 times greater chance (221%
increased chance) to experience sealant retention loss
compared with the participants who received resin-
modified GI sealants (OR, 3.21; 95%CI, 1.87-5.51; P< .0001)
(eFigure 12, available online at the end of this article).
Because only 1 study informed this outcome, we did not
perform a subgroup analysis.We assessed the quality of the
evidence asmoderate, owing to serious issues related to risk
of bias (eTable 2, available online at the end of this article).
We did not find any studies whose investigators had
reported data on caries incidence for the 4- to 7-year
follow-up category and the more than 7 years of follow-
up category for this comparison and outcome.
Comparison 5. Resin-modified glass ionomer sealants
versus polyacid-modified resin sealants. Caries inci-
dence. The results of 1 study38 (186 participants) informed
the comparison and outcome for the 2- to 3-year follow-up
category. In relative terms, participants who received
resin-modified GI sealants had a 56% reduction in the risk
of developing new carious lesions compared with partic-
ipants who received polyacid-modified resin sealants (OR,
0.44; 95% CI, 0.11-1.82); however, this difference was not
statistically significant (P ¼ .26) (eFigure 13, available on-
line at the end of this article). Because only 1 study
informed this outcome, we did not perform a subgroup
analysis. We assessed the quality of the evidence for this
outcome as very low, owing to serious issues related to risk
of bias and very serious issues related to imprecision
(eTable 3, available online at the end of this article).
We did not find any studies whose investigators had
reported data on caries incidence for the 4- to 7-year
follow-up category and the more than 7 years of follow-
up category for this comparison and outcome.
Lack of retention. The results of 1 study38 that
included 186 participants informed the comparison and
outcome for the 2- to 3-year follow-up category.38 In
relative terms, participants who received resin-modifiedJADA 147(8) http://jada.ada.org August 2016 639
TABLE 3
Evidence profile: sealants compared with nonuse of sealants in pit-and-fissure
occlusal surfaces in children and adolescents.*
QUALITY ASSESSMENT
No. of Studies Study Design Risk of Bias Inconsistency Indirectness Imprecision Other Considerations
Caries incidence (follow-up: range 2-3 y)‡
9 Randomized trials Serious§ Not serious Not serious Not serious None
Caries incidence (follow-up: range 4-7 y)#
3 Randomized trials Serious§ Serious** Not serious Not serious None
Caries incidence (follow-up: range 7 y or more)#
2 Randomized trials Serious§ Not serious Not serious Not serious None
Lack of retention (follow-up: range 2-3 y)
9 Randomized trials Serious§ Not serious Not serious Not serious None
* Sources: Splieth and colleagues,1 Bojanini and colleagues,19 Bravo and colleagues,20 Erdogan and colleagues,21 Liu and colleagues,22 Mertz-
Fairhurst and colleagues,23 Pereira and colleagues,24 Richardson and colleagues,25 Tagliaferro and colleagues.26
† The percentages (30% and 70%) indicate the control group baseline risk (caries prevalence).
‡ A subgroup analysis conducted to determine whether there was a difference in the caries incidence depending on whether the sealant was placed
in patients with noncavitated carious lesions or deep fissures and pits, no caries in the occlusal surface, and a mix of caries free and noncavitated
carious lesions, showed no statistically significant differences (P ¼ .58). Studies including a mixed population (recruiting both patients with
noncavitated initial occlusal caries and caries-free occlusal surfaces) showed a 76% reduction in caries incidence after 2- to 3-y follow-up (odds
ratio, 0.24; 95% confidence interval, 0.19-0.30).
§ Most studies were classified as unclear for the “allocation concealment” and “masking” domains.
¶ 4 of 9 studies reported being conducted in water-fluoridated communities.
# Studies only reported data for this outcome in patients who were caries-free. Patients with noncavitated carious lesions or deep pits and fissures
were not included in the studies.
** Unexplained heterogeneity (P < .0001, I2 ¼ 77%).
†† 2 of 3 studies reported being conducted in water-fluoridated communities.
‡‡ 2 of 2 studies reported being conducted in water-fluoridated communities.
ORIGINAL CONTRIBUTIONSGI sealants had a 17% increased risk of experiencing
sealant retention loss compared with the participants
who received polyacid-modified resin sealants (OR, 1.17;
95% CI, 0.52-2.66); however, this difference was not
statistically significant (P ¼ .70) (eFigure 14, available
online at the end of this article). Because only 1 study
informed this outcome, we did not perform subgroup
analysis. We assessed the quality of the evidence as very
low, owing to serious issues related to risk of bias and
very serious issues related to imprecision (eTable 3,
available online at the end of this article).
We did not find any studies whose investigators had
reported data for this comparison with regard to the
outcome of lack of sealant retention for the 4- to 7-year
follow-up category and the more than 7 years of follow-
up category.
Comparison 6. Polyacid-modified resin sealants
versus resin-based sealants. Caries incidence. The results
of 2 studies37,38 (322participants) informed the comparison
and outcome for the 2- to 3-year follow-up category. In640 JADA 147(8) http://jada.ada.org August 2016relative terms, participants who received polyacid-
modified resin sealants had a 1% increased risk of devel-
oping new carious lesions comparedwith participants who
received resin-based sealants (OR, 1.01; 95% CI, 0.48-2.14);
however, this difference was not statistically significant
(P ¼ .97) (eFigure 15, available online at the end of this
article). We were unable to find evidence of heterogeneity
(c2 P ¼ .39; I2 ¼ 0%). Because the investigators of the 2
studies included only participants with sound occlusal
surfaces, we did not perform a subgroup analysis. We
assessed the quality of the evidence for this outcome as
very low, owing to serious issues related to risk of bias and
very serious issues related to imprecision (eTable 4,
available online at the end of this article).
We did not find any studies whose investigators had
reported data on caries incidence for the 4- to 7-year
follow-up category and the more than 7 years of follow-
up category for this comparison and outcome.
Lack of retention. The results of 2 studies37,38 (322
participants) informed the comparison and outcome for
TABLE 3 (CONTINUED)
PATIENTS (N) EFFECT QUALITY IMPORTANCE
Sealants Nonuse of
Sealants†
Relative Odds Ratio
(95% Confidence
Interval)
Absolute (95% Confidence
Interval)
194/1,799 (10.8%) 584/1,743 (33.5%)¶ 0.24 (0.19-0.30) 248 fewer per 1,000 (221-271 fewer) Moderate Critical
30.0% 207 fewer per 1,000 (186-225 fewer)
70.0% 341 fewer per 1,000 (288-393 fewer)
74/368 (20.1%) 206/384 (53.6%)†† 0.21 (0.10-0.44) 341 fewer per 1,000 (199-433 fewer) Low Critical
30.0% 217 fewer per 1,000 (141-259 fewer)
70.0% 371 fewer per 1,000 (193-511 fewer)
62/215 (28.8%) 170/231 (73.6%)‡‡ 0.15 (0.08-0.27) 441 fewer per 1,000 (307-554 fewer) Moderate Critical
30.0% 240 fewer per 1,000 (196-267 fewer)
70.0% 441 fewer per 1,000 (313-543 fewer)
Including all sealant material types and tooth preparation techniques, 55.6% of sealants were fully retained
at 2 y, and 59.3% were fully or partially retained at 2 y; at 3 y, 56.4% of all sealants were fully retained,
and 58.8% were fully or partially retained after 3.6 y
Moderate Important
ORIGINAL CONTRIBUTIONSthe 2- to 3-year follow-up category. In relative terms,
participants who received polyacid-modified resin seal-
ants had a 23% reduction in the risk of experiencing
sealant retention loss compared with participants who
received resin-based sealants (OR, 0.87; 95% CI,
0.12-6.21); however, this difference was not statistically
significant (P ¼ .89) (eFigure 16, available online at the
end of this article). Because the investigators of the 2
studies included only participants with sound occlusal
surfaces, we did not perform a subgroup analysis. We
assessed the quality of the evidence for this outcome as
very low, owing to serious issues related to risk of bias,
inconsistency (c2 P ¼ .02; I2 ¼ 81%), and imprecision
(eTable 4, available online at the end of this article).
We did not find any studies whose investigators had
reported data for this comparison with regard to the
outcome of lack of sealant retention for the 4- to 7-year
follow-up category and the more than 7 years of follow-
up category.
Safety of sealants. The investigators of 2 studies22,42
sought to measure adverse events associated with the use
of sealants. The investigators of these RCTs were unable
to identify any adverse events among the participants.
DISCUSSION
Summary of the results. The results of this systematic
review suggest that children and adolescents who receive
sealants in sound occlusal surfaces or noncavitated pit-
and-fissure carious lesions in their primary or permanent
molars (compared with a control without sealants)
experienced a 76% reduction in the risk of developingnew carious lesions after 2 years of follow-up. Even after
7 or more years of follow-up, children and adolescents
with sealants had a caries incidence of 29%, whereas
those without sealants had a caries incidence of 74%.
We assessed the quality of the evidence as being mod-
erate, owing to serious issues related to the risk of bias.
Furthermore, low-quality evidence (owing to serious
issues related to the risk of bias and inconsistency)
suggested that sealants applied to the pits and fissures
of primary and permanent molars may be more benefi-
cial compared with the application of fluoride varnishes
after 7 or more years of follow-up (that is, 290 fewer
carious lesions over 1,000; ranging from 176 fewer carious
lesions over 1,000, to 381 fewer carious lesions over
1,000). We did not identify any studies whose in-
vestigators provided information about the effect of
sealants in adults.
The head-to-head analysis of the effect of sealant
materials on caries incidence and retention loss did
not provide enough evidence for us to reliably offer a
description of the relative merits of each sealant material.
When making clinical decisions, we suggest that clini-
cians take into account the likelihood that their patients
will experience a lack of retention inherent to the sealant
material as well as their ability to isolate and maintain a
dry field during placement.
Quality of the evidence. We found moderate-quality
evidence for the outcome of caries incidence in the
comparison of sealants versus the control without seal-
ants. When we tried to make more specific comparisons,
we found that the quality of the evidence decreased toJADA 147(8) http://jada.ada.org August 2016 641
TABLE 4
Evidence profile: glass ionomer sealants compared with resin-based sealants in
pit-and-fissure occlusal surfaces in children and adolescents.*
QUALITY ASSESSMENT
No. of Studies Study Design Risk of Bias Inconsistency Indirectness Imprecision Other Considerations
Caries incidence (follow-up: range 2-3 y)‡,§
10 Randomized trials Serious¶ Serious# Not serious Serious** None
Caries incidence (follow-up: range 4-7 y)‡‡
2 Randomized trials Serious§§ Not serious Not serious Very serious¶¶ None
Caries incidence (follow-up: range 7 y or more)—not reported
—## — — — — — —
Lack of retention (follow-up: range 2-3 y)
10 Randomized trials Serious¶ Serious*** Not serious Not serious None
Lack of retention (follow-up: range 4-7 y)
2 Randomized trials Serious§§ Not serious Not serious Serious††† None
Lack of retention—not reported
— — — — — — —
* Sources: Amin,28 Antonson and colleagues,29 Arrow and Riordan,30 Baseggio and colleagues,32 Chen and colleagues,33,41 Chen and Liu,34 Dhar
and Chen,35 Guler and Yilmaz,36 Pardi and colleagues,38 and Haznedaroglu and Guner.39
† The percentages (30% and 70%) indicate the control group baseline risk (caries prevalence).
‡ A subgroup analysis conducted to determine whether there was a difference in the caries incidence depending on whether the sealant was placed
in noncavitated carious lesions or deep fissures and pits, no caries in the occlusal surface, and a mix of caries free and noncavitated carious lesions,
showed no statistically significant differences (odds ratio, 1.53; 95% confidence interval, 0.58-4.07; P ¼ .19).
§ One additional study including 200 participants that was not included in the meta-analysis due to the data presentation failure to show a clinically
or statistically significant difference in caries incidence when glass ionomer sealants and resin-based sealants were placed in the occlusal surfaces
of primary and permanent teeth.
¶ Most studies were classified as unclear for the “allocation concealment” and “masking” domains.
# Unexplained heterogeneity (P < .00001, I2 ¼ 81%).
** 95% confidence interval suggests large benefit and a large harm (95% confidence interval, 68% reduction-57% increase).
†† 1 of 10 studies reported being conducted in water-fluoridated communities.
‡‡ Only 2 studies reported this outcome. No subgroup analysis was conducted.
§§ The “randomization” and “allocation concealment” domains were classified as “unclear” risk of bias for most studies.
¶¶ 95% confidence interval suggests a large benefit and a large harm (95% confidence interval, 96% reduction-0% increase).
## Dashes indicate data not available.
*** Unexplained heterogeneity (P # .00001, I2 ¼ 97%).
††† 95% confidence interval suggests a large benefit and a large harm (95% confidence interval, 85% reduction-2,695% increase).
ORIGINAL CONTRIBUTIONSlow or very low for most of the outcomes measured
related to the head-to-head sealant comparisons. The
main issues we identified among the comparisons related
to risk of bias, inconsistency, and imprecision.
Comparison with previous reviews. The authors of
1 Cochrane review published in 20137 summarized the
effect of sealants compared with a control without
sealants and multiple head-to-head comparisons.
Although for our study, we differed in the inclusion and
exclusion of some of the studies they included, their
results also suggested that sealants prevent carious le-
sions in children and adolescents. Their assessment of
the quality of the evidence at different end points also
decreased from the shortest to the longest follow-up, in
agreement with the results of our evaluation. The au-
thors of another Cochrane review conducted in 201643642 JADA 147(8) http://jada.ada.org August 2016summarized the evidence on the effect of sealants versus
fluoride varnishes in children aged 5 to 10 years. Again,
although we differed in the inclusion and exclusion of
some studies, their conclusions in relation to the effect of
sealants and the assessment of the quality of the evidence
coincidewith ours.43The authors of yet another systematic
review published in 201644 aimed to determine the effec-
tiveness of high-viscosity GI sealants comparedwith resin-
based sealants. Finally, the authors of a systematic review
published in 2016 on the use of adhesive systems under
fissure sealants45 concluded that bonding agents could
increase the retention of sealants. These authors did not
include dental caries as an outcome, and they further
concluded that there was insufficient evidence to make
comparisons among different generations of adhesive
systems.45
TABLE 4 (CONTINUED)
PATIENTS (N) EFFECT QUALITY IMPORTANCE
Glass Ionomer
Sealants
Resin-Based
Sealants†
Relative Odds Ratio
(95% Confidence
Interval)
Absolute (95% Confidence
Interval)
179/2,727 (6.6%) 141/2,014 (7.0%)†† 0.71 (0.32-1.57) 19 fewer per 1,000 (36 more-46 fewer) Very low Critical
30.0% 67 fewer per 1,000 (102 more-179 fewer)
70.0% 76 fewer per 1,000 (86 more-273 fewer)
6/61 (9.8%) 19/84 (22.6%) 0.37 (0.14-1.00) 154 fewer per 1,000 (0-228 fewer) Very low Critical
30.0% 163 fewer per 1,000 (0-243 fewer)
70.0% 237 fewer per 1,000 (0-454 fewer)
— — — — — Critical
1,875/2,727 (68.8%) 596/2,014 (29.6%) 5.06 (1.81-14.13) 384 more per 1,000 (136-560 more) Low Important
46/61 (75.4%) 50/84 (59.5%) 2.08 (0.15-27.95) 158 more per 1,000 (381 more-415 fewer) Low Important
— — — — — Important
ORIGINAL CONTRIBUTIONSStrength and limitations of this review. The strength
of this systematic review lies in the rigor of its method-
ology, which follows the recommendations in the
Cochrane Handbook for Systematic Reviews of Interven-
tion.46 For example, we conducted screening and data
extraction in duplicate, pooled the results of split-mouth
and parallel design trials, adjusting for the dependence
of the observations, and we assessed the quality of the
evidence using the GRADE approach.17 Limitations
included our inability to contact primary authors of the
studies to clarify issues related to risk of bias or specific
study features owing to the fact that most of the included
trials were published more than 20 years ago, and the
inability to assess publication bias by means of using a
funnel plot owing to the limited number of included
studies per outcome.
CONCLUSIONS
In summary, we found moderate-quality evidence to
suggest that the use of sealants when compared with
control groups that did not have sealants reduces the
incidence of carious lesions in the occlusal surfaces of
permanent molars by approximately 80% in children and
adolescents. When comparing this finding with the results
associated with fluoride varnishes, we found that sealants
still were associated with a reduction in the incidence of
carious lesions in the occlusal surfaces of permanent
molars of approximately 70%, which, in this case, was
supported by low-quality evidence. Also, we found thatnone of the investigators of the studies reported adverse
outcomes. Finally, although in our analysis we failed to
find a hierarchy of effectiveness, which prevented us from
making strong statements about the relativemerits of each
sealant material, we did find that sealants compared with
no sealants or fluoride varnishes prove superior in pre-
venting carious lesions and arresting the progression of
noncavitated carious lesions. nSUPPLEMENTAL DATA
Supplemental data related to this article can be found at
http://dx.doi.org/10.1016/j.adaj.2016.06.003.
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Appendix.
SEARCH STRATEGIES AND ELECTRONIC DATABASES
CONSULTED.
SEARCHES CONDUCTED IN NOVEMBER 2013.
MEDLINE (via PubMed). ((“Pit and Fissure Seal-
ants”[Mesh]) OR ((tetric[tiab] OR vitremer[tiab] OR
fluoroshield[tiab] OR delton[tiab] OR kerr[tiab]
OR lispro[tiab] OR dyract[tiab] OR revolution[tiab] OR
oralis[tiab] OR ketac[tiab] OR concise[tiab]) AND
sealant*) OR (composite* AND sealant*[tiab]) OR
(fissure* AND sealant*) OR (fissure*[tiab] AND sealant*
[tiab]) OR (composite* AND sealant*) OR (dent* AND
sealant*) OR (sealant* AND resin*) OR (Compomer*
AND sealant*) OR ((“glass ionomer$” OR “Resins,
Synthetic”[Mesh] OR “Resins, Synthetic”[Pharmaco-
logical Action] OR “Bisphenol A-Glycidyl Meth-
acrylate”[Mesh] OR glassionomer* OR “Glass Ionomer
Cements”[Mesh]) AND sealant*)) AND (randomized
controlled trial[pt] OR controlled clinical trial[pt] OR
randomized[tiab] OR placebo[tiab] OR clinical trials as
topic[mesh:noexp] OR randomly[tiab] OR trial[ti] NOT
(animals[mh] NOT humans[mh]))
Embase. The following search strategy was linked to
the Cochrane Highly Sensitive Search Strategy for
identifying randomized trials:
1. ‘pit and fissure sealants’/exp
2. fissure* NEAR/6 seal*
3. dental NEAR/6 seal*
4. resin* NEAR/6 seal*
5. compomer* NEAR/6 seal*
6. composite* NEAR/6 seal*
7. exp Glass Ionomer Cements/
8. exp Resins, Synthetic/
9. glass NEXT/1 ionomer* or glassionomer* 10. 7 or 8 or
9 11. seal* 12. 10 and 11 13. 1 or 2 or 3 or 4 or 5 or 6 or 12
14. . (tetric OR vitremer OR fluoroshield OR delton
OR kerr OR lispro OR dyract OR revolution OR oralis
OR ketac OR concise) .tw.
Cochrane Central Register of Controlled Trials
(CENTRAL).
1. fissure*
2. MeSH descriptor: [Composite Resins] explode all
trees
3. MeSH descriptor: [Pit and Fissure Sealants] explode
all trees
4. MeSH descriptor: [Glass Ionomer Cements] explode
all trees
5. dental
6. resin*
7. compomer*
8. sealant*
9. composite*
10. “glass ionomer*”
11. glassionomer*
12. (#2or #4 or #5 or #6or #7or #9or #10or #11or #1) and#8
13. #3 or #12
ClinicalTrials.gov. Dental and sealant
LILACS.
- (selantes OR sellantes OR sealants) OR (pit and fissure
sealants) AND ((Pt RANDOMIZED CONTROLLED
TRIALORPt CONTROLLEDCLINICALTRIALORMh
RANDOMIZED CONTROLLED TRIALS OR Mh
RANDOM ALLOCATION OR Mh DOUBLE-BLIND
METHOD OR Mh SINGLE-BLINDMETHOD OR Pt
MULTICENTER STUDY)OR ((tw ensaio or tw ensayo or
tw trial) and (tw azar or tw acaso or tw placebo or tw
control$ or tw aleat$ or tw random$ or (tw duplo and tw
cego) or (tw doble and tw ciego) or (tw double and tw
blind)) and tw clinic$)) AND NOT ((CT ANIMALS OR
MH ANIMALS OR CT RABBITS OR CT MICE OR MH
RATS OR MH PRIMATES OR MH DOGS OR MH
RABBITS OR MH SWINE) AND NOT (CT HUMAN
AND CT ANIMALS))
- tetric OR vitremer OR fluoroshield OR delton OR kerr
OR lispro OR dyract OR revolution OR oralis OR ketac
OR concise [Words] and ((Pt RANDOMIZED
CONTROLLED TRIAL OR Pt CONTROLLED CLIN-
ICAL TRIAL OR Mh RANDOMIZED CONTROLLED
TRIALS OR Mh RANDOM ALLOCATION OR Mh
DOUBLE-BLIND METHOD OR Mh SINGLE-
BLINDMETHOD OR Pt MULTICENTER STUDY) OR
((tw ensaio or tw ensayo or tw trial) and (tw azar or tw
acaso or tw placebo ortw control$ or tw aleat$ or tw
random$ or (tw duplo and tw cego) or (tw doble and tw
ciego) or (tw double and tw blind)) and tw clinic$)) AND
NOT ((CT ANIMALS OR MH ANIMALS OR CT RAB-
BITS OR CT MICE OR MH RATS OR MH PRIMATES
ORMHDOGSORMHRABBITSORMHSWINE) AND
NOT (CT HUMAN AND CT ANIMALS))
-Composta OR composite [Words] AND selante
OR sellante [Words] and ((Pt RANDOMIZED
CONTROLLED TRIAL OR Pt CONTROLLED CLIN-
ICAL TRIAL OR Mh RANDOMIZED CONTROLLED
TRIALS OR Mh RANDOM ALLOCATION OR Mh
DOUBLE-BLIND METHOD OR Mh SINGLE-
BLINDMETHOD OR Pt MULTICENTER STUDY) OR
((tw ensaio or tw ensayo or tw trial) and (tw azar or tw
acaso or tw placebo ortw control$ or tw aleat$ or tw
random$ or (tw duplo and tw cego) or (tw doble and tw
ciego) or (tw double and tw blind)) and tw clinic$))
AND NOT ((CT ANIMALS OR MH ANIMALS OR CT
RABBITS OR CT MICE OR MH RATS OR MH PRI-
MATES OR MH DOGS OR MH RABBITS OR MH
SWINE) AND NOT (CT HUMAN AND CT ANI-
MALS)) [Words]
- resin OR resina [Words] and selante OR sellante
[Words] and ((Pt RANDOMIZED CONTROLLED
TRIAL OR Pt CONTROLLED CLINICAL TRIAL OR
Mh RANDOMIZED CONTROLLED TRIALS OR Mh
RANDOM ALLOCATION OR Mh DOUBLE-BLIND
METHOD OR Mh SINGLE-BLINDMETHOD OR Pt
MULTICENTER STUDY) OR ((tw ensaio or tw ensayo
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or tw trial) and (tw azar or tw acaso or tw placebo ortw
control$ or tw aleat$ or tw random$ or (tw duplo and tw
cego) or (tw doble and tw ciego) or (tw double and tw
blind)) and tw clinic$)) AND NOT ((CT ANIMALS OR
MH ANIMALS OR CT RABBITS OR CT MICE OR MH
RATS OR MH PRIMATESOR MH DOGS OR MH
RABBITS OR MH SWINE) AND NOT (CT HUMAN
AND CT ANIMALS)) [Words] [Words]
- ionômero [Words] and selante OR sellante [Words]
and ((Pt RANDOMIZED CONTROLLED TRIAL OR Pt
CONTROLLED CLINICAL TRIAL OR Mh RAN-
DOMIZED CON-TROLLED TRIALS OR Mh
RANDOM ALLOCATION OR Mh DOUBLE-BLIND
METHOD OR Mh SINGLE-BLINDMETHOD OR Pt
MULTICENTER STUDY) OR ((tw ensaio or tw ensayo
or tw trial) and (tw azar or tw acaso or tw placebo ortw
control$ or tw aleat$ or tw random$ or (tw duplo and tw
cego) or (tw doble and tw ciego) or (tw double and tw
blind)) and tw clinic$)) AND NOT ((CT ANIMALS OR
MH ANIMALS OR CT RABBITS OR CT MICE OR MH
RATS OR MH PRIMATESOR MH DOGS OR MH
RABBITS OR MH SWINE) AND NOT (CT HUMAN
AND CT ANIMALS)) [Words]
-Bisphenol A-Glycidyl Methacrylate [Words] and
selante OR sellante [Words] and ((Pt RANDOMIZED
CONTROLLED TRIAL OR Pt CONTROLLED CLIN-
ICAL TRIAL OR Mh RANDOMIZED CONTROLLED
TRIALS OR Mh RANDOM ALLOCATION OR Mh
DOUBLE-BLIND METHOD OR Mh SINGLE-
BLINDMETHOD OR Pt MULTICENTER STUDY) OR
((tw ensaio or tw ensayo or tw trial) and (tw azar or tw
acaso or tw placebo ortw control$ or tw aleat$ or tw
random$ or (tw duplo and tw cego) or (tw doble and tw
ciego) or (tw double and tw blind)) and tw clinic$))
AND NOT ((CT ANIMALS OR MH ANIMALS OR CT
RABBITS OR CT MICE OR MH RATS OR MH PRI-
MATES OR MH DOGS OR MH RABBITS OR MH
SWINE) AND NOT (CT HUMAN AND CT ANI-
MALS)) [Words]
SEARCHES CONDUCTED IN FEBRUARY 2014 AND
MAY 2016
PubMed. ((“Pit and Fissure Sealants”[Mesh]) OR
((tetric[tiab] OR vitremer[tiab] OR fluoroshield[tiab]
OR delton[tiab] OR kerr[tiab] OR lispro[tiab] OR dyract
[tiab] OR revolution[tiab] OR oralis[tiab] OR ketac[tiab]
OR concise[tiab]) AND sealant*) OR (composite* AND
sealant*[tiab]) OR (fissure* AND sealant*) OR (fissure*
[tiab] AND sealant*[tiab]) OR (composite* AND
sealant*) OR (dent* AND sealant*) OR (sealant* AND
resin*) OR (Compomer* AND sealant*) OR ((“glass
ionomer$” OR “Resins, Synthetic”[Mesh] OR “Resins,
Synthetic”[Pharmacological Action] OR “Bisphenol
A-Glycidyl Methacrylate”[Mesh] OR glassionomer* OR
“Glass Ionomer Cements”[Mesh]) AND sealant*)) AND
(randomized controlled trial[pt] OR controlled clinical
trial[pt] OR randomized[tiab] OR placebo[tiab] OR
clinical trials as topic[mesh:noexp] OR randomly[tiab]
OR trial[ti] NOT (animals[mh] NOT humans[mh]))
Cochrane Central Register of Controlled Trials
(CENTRAL).
1. fissure*
2. MeSH descriptor: [Composite Resins] explode all
trees
3. MeSH descriptor: [Pit and Fissure Sealants] explode
all trees
4. MeSH descriptor: [Glass Ionomer Cements] explode
all trees
5. dental
6. resin*
7. compomer*
8. sealant*
9. composite*
10. “glass ionomer*”
11. glassionomer*
12. (#2 or #4 or #5 or #6 or #7 or #9 or #10 or #11 or #1)
and #8
13. #3 or #12
ClinicalTrials.gov. dental AND sealant
ORIGINAL CONTRIBUTIONS
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1.1.1 Carious or deep fissures
Study or Subgroup Log (Odds Ratio) SE
Sealants
Total
No Sealants
Total Weight
Favors sealants Favors no sealants
Odds Ratio
IV, Random, 95% CI
0.1 0.2 0.5 1 2 5 10
Odds Ratio
IV, Random, 95% CI
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
Heterogeneity: τ2 = 0.10; χ25 = 11.05, P = .05; I
2 = 55%
Test for overall effect: z = 8.50 (P < .00001)
1.1.2 No caries
Bravo and Colleagues,20 1996 13.6% 0.14 (0.09-0.23)
Bojanini and Colleagues,19 1976 3.6% 0.15 (0.05-0.51)
Pereira and Colleagues,24 2003 16.2% 0.19 (0.13-0.28)
Mertz-Fairhurst and Colleagues,23 1984 13.1% 0.20 (0.12-0.33)
Tagliaferro and Colleagues,26 2011 11.8% 0.39 (0.23-0.67)
Erdogan and Alacam,21 1987 8.2% 0.39 (0.19-0.81)
Subtotal (95% CI) 66.5% 0.22 (0.16-0.32)
Heterogeneity: τ2 = 0.00; χ22 = 1.74, P = .42; I
2 = 0%
Test for overall effect: z = 9.18 (P < .00001)
Heterogeneity: τ2 = 0.05; χ28 = 13.58, P = .09; I
2 = 41%
Test for overall effect: z = 11.68 (P < .00001)
Test for subgroup differences: χ21 = 0.30, P = .58; I
2 = 0%
1.1.3 Mixed
Richardson and Colleagues,25 1980 17.9% 0.23 (0.16-0.32)
Splieth and Colleagues,1 2001 7.3% 0.26 (0.12-0.57)
Liu and Colleagues,22 2012
–1.95
–1.865
–1.669
–1.616
–0.943
–0.93
–1.481
–1.338
–0.948
0.244
0.612
0.203
0.253
0.277
0.364
0.18
0.396
0.363 8.3% 0.39 (0.19-0.79)
Subtotal (95% CI) 33.5% 0.25 (0.19-0.34)
Total (95% CI)
0
238
42
342
201
0
96
919
337
176
367
880
1,799
0
272
42
240
201
0
96
851
337
176
379
892
1,743 100.0% 0.24 (0.19-0.30)
eFigure 1. Forest plot of comparison. 1. Sealants versus nonuse of sealants, outcome: 1.1 Caries incidence (2-3 years). CI: Confidence interval.
IV: Inverse-variance. SE: Standard error.
Odds Ratio
IV, Random, 95% CI
1.2.1 Carious or deep fissures
Study or Subgroup Log (Odds Ratio) SE Weight
Favors sealants Favors no sealants
0.05 0.2 1 5 20
Odds Ratio
IV, Random, 95% CI
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
1.2.3 Mixed
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
Heterogeneity: τ2 = 0.31; χ22 = 8.66, P = .01; I
2 = 77%
Test for overall effect: z = 4.20 (P < .0001)
1.2.2 No caries
Subtotal (95% CI) 100.0% 0.21 (0.10-0.44)
Bravo and Colleagues,20 1996 32.7% 0.10 (0.05-0.19)
Mertz-Fairhurst and Colleagues,23 1984 36.7% 0.25 (0.16-0.40)
Erdogan and Alacam,21 1987
–2.287
–1.387
–0.93
0.32
0.24
0.364 30.5% 0.39 (0.19-0.81)
Heterogeneity: τ2 = 0.31; χ22 = 8.66, P = .01; I
2 = 77%
Test for overall effect: z = 4.20 (P < .0001)
Test for subgroup differences: Not applicable
Total (95% CI)
0
0
368
113
159
96
368
0
0
384
129
159
96
384 100.0% 0.21 (0.10-0.44)
Sealants
Total
No Sealants
Total
eFigure 2. Forest plot of comparison. 1. Sealants versus nonuse of sealants, outcome: 1.2 Caries incidence (4-7 years). CI: Confidence interval.
IV: Inverse-variance. SE: Standard error.
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Odds Ratio
IV, Random, 95% CI
1.3.1 Carious or deep fissures
Study or Subgroup Log (Odds Ratio) SE
Sealants
Total
No Sealants
Total Weight
Odds Ratio
IV, Random, 95% CI
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
1.3.3 Mixed
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
Heterogeneity: τ2 = 0.09; χ21 = 1.99, P = .16; I
2 = 50%
Test for overall effect: z = 6.38 (P < .00001)
1.3.2 No caries
Subtotal (95% CI) 0.15 (0.08-0.27)
Bravo and Colleagues,20 1996 0.298 0.11 (0.06-0.20)
Mertz-Fairhurst and Colleagues,23 1984
–2.211
–1.611 0.303 0.20 (0.11-0.36)
Heterogeneity: τ2 = 0.09; χ21 = 1.99, P = .16; I
2 = 50%
Test for overall effect: z = 6.38 (P < .00001)
Test for subgroup differences: Not applicable
Total (95% CI)
0
0
215
113
102
215
0
0
231
129
102
231
100.0%
50.4%
49.6%
100.0% 0.15 (0.08-0.27)
Favors sealants Favors no sealants
0.01 0.1 1 10 100
eFigure 3. Forest plot of comparison. 1. Sealant versus nonuse of sealant, outcome: 1.3 Caries incidence (7 years or more). CI: Confidence interval.
IV: Inverse-variance. SE: Standard error.
Odds Ratio
IV, Random, 95% CI
2.1.1 Carious or deep fissures
Study or Subgroup Log (Odds Ratio) SE
Sealants
Total
Fluoride
Varnishes Total Weight
Odds Ratio
IV, Random, 95% CI
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
2.1.3 Mixed
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: z = 1.04 (P = .3)
0.66 (0.30-1.44)
Heterogeneity: τ2 = 0.39; χ21 = 7.66, P = .006; I
2 = 87%
Test for overall effect: z = 3.54 (P = .0004)
2.1.2 No caries
Subtotal (95% CI) 0.19 (0.07-0.47)
Houpt and Shey,27 1983 0.12 (0.07-0.18)
Liu and Colleagues,22 2012 0.66 (0.30-1.44)
Bravo and Colleagues,20 1996
–2.15
–0.414
–1.2
0.232
0.398
0.253 0.30 (0.18-0.49)
Heterogeneity: τ2 = 0.59; χ22 = 16.69, P = .002; I
2 = 88%
Test for overall effect: z = 2.73 (P = .006)
Test for subgroup differences:  χ21 = 4.18, P = .04; I
2 = 76.1%
Total (95% CI)
0
367
488
250
367
238
855
0
358
502
250
358
252
860
30.2%
69.8%
35.2%
30.2%
34.6%
100.0% 0.27 (0.11-0.69)
Favors sealants Favors varnishes
0.01 0.1 1 10 100
eFigure 4. Forest plot of comparison. 2. Sealants versus fluoride varnishes, outcome: 2.1 Caries incidence (2-3 years). CI: Confidence interval.
IV: Inverse-variance. SE: Standard error.
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Odds Ratio
IV, Random, 95% CI
2.2.1 Carious or deep fissures
Study or Subgroup Log (Odds Ratio) SE
Sealants
Total
Fluoride
Varnishes Total Weight
Odds Ratio
IV, Random, 95% CI
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
2.2.3 Mixed
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
Heterogeneity: τ2 = 0.38; χ21 = 4.99, P = .03; I
2 = 80%
Test for overall effect: z = 3.34 (P = .0008)
2.2.2 No caries
Subtotal (95% CI) 0.19 (0.07-0.51)
Houpt and Shey,27 1983 0.12 (0.07-0.22)
Bravo and Colleagues,20 1996
–2.12
–1.14
0.3
0.32 0.32 (0.17-0.60)
Heterogeneity: τ2 = 0.38; χ21 = 4.99, P = .03; I
2 = 80%
Test for overall effect: z = 3.34 (P = .0008)
Test for subgroup differences: Not applicable
Total (95% CI)
0
0
228
115
113
228
0
0
244
115
129
244
100.0%
50.6%
49.4%
100.0% 0.19 (0.07-0.51)
Favors sealants Favors varnishes
0.01 0.1 1 10 100
eFigure 5. Forest plot of comparison. 2. Sealants versus fluoride varnishes, outcome: 2.2 Caries incidence (4-7 years). CI: Confidence interval.
IV: Inverse-variance. SE: Standard error.
Odds Ratio
IV, Random, 95% CI
2.3.1 Carious or deep fissures
Study or Subgroup Log (Odds Ratio) SE
Sealants
Total
Fluoride
Varnishes Total Weight
Odds Ratio
IV, Random, 95% CI
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
2.3.3 Mixed
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
Heterogeneity: Not applicable
Test for overall effect: z = 4.52 (P < .00001)
2.3.2 No caries
Subtotal (95% CI) 0.29 (0.17-0.49)
Bravo and Colleagues,20 1996 –1.251 0.277 0.29 (0.17-0.49)
Heterogeneity: Not applicable
Test for overall effect: z = 4.52 (P < .00001)
Test for subgroup differences: Not applicable
Total (95% CI)
0
0
113
113
113
0
0
129
129
129
100.0%
100.0%
100.0% 0.29 (0.17-0.49)
Favors sealants Favors varnishes
0.01 0.1 1 10 100
eFigure 6. Forest plot of comparison. 2. Sealants versus fluoride varnishes, outcome: 2.3 Caries incidence (7 years or more). CI: Confidence interval.
IV: Inverse-variance. SE: Standard error.
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Odds Ratio
IV, Random, 95% CI
3.1.1 Carious or deep fissures
Study or Subgroup Log (Odds Ratio) SE
Glass
Ionomer Total
Resin-Based
Total Weight
Odds Ratio
IV, Random, 95% CI
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: z = 0.86 (P = .39)
1.53 (0.58-4.07)
3.1.3 Mixed
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
Heterogeneity: τ2 = 1.33; χ28 = 47.77, P < .00001; I
2 = 83%
Test for overall effect: z = 0.99 (P = .32)
3.1.2 No caries
Subtotal (95% CI)
Chen and Colleagues,33,41 2012 
Amin,28 2008
Antonson and Colleagues,29 2012
Arrow and Riordan,30 1995
Baseggio and Colleagues,32 2010
Chen and Liu,34 2013
Dhar and Chen,35 2012
Guler and Yilmaz,36 2013
Haznedaroglu and Colleagues,39 2016
Pardi and Colleagues,38 2005
0.63
1.19
0.24
0.18
2.56
1.00
0.39
0.41
1.08
0.55
(0.25-1.57)
(0.10-13.82)
(0.01-5.48)
(0.08-0.44)
(1.83-3.58)
(0.31-3.25)
(0.10-1.61)
(0.18-0.95)
(0.07-17.58)
(0.15-2.04)
0.178
–1.444
–1.7
0.941
0
–0.936
–0.883
0.076
–0.6
0.427
1.249
1.605
0.451
0.171
0.601
0.721
0.422
1.424
0.671
0.498 1.53 (0.58-4.07)
Heterogeneity: τ2 = 1.10; χ29 = 47.84, P < .00001; I
2 = 81%
Test for overall effect: z = 0.85 (P = .39)
Test for subgroup differences: χ21 = 1.69, P = .19; I
2 = 40.9%
Total (95% CI)
1,282
0
1,445
24
27
412
628
75
50
68
64
97
1,282
2,727
452
0
1,562
54
27
412
628
75
50
66
68
182
452
2,014
12.2%
87.8%
6.2%
4.5%
12.6%
14.5%
11.2%
10.1%
12.8%
5.3%
10.6%
12.2%
100.0% 0.71 (0.32-1.57)
Favors glass ionomer Favors resin-based
0.01 0.1 1 10 100
eFigure 7. Forest plot of comparison 3. Overall: Glass ionomer sealants versus resin-based sealants, outcome: 3.1 Caries incidence (2-3 years).
CI: Confidence interval. IV: Inverse-variance. SE: Standard error.
Odds Ratio
IV, Random, 95% CI
3.2.1 Mixed
Study or Subgroup Log (Odds Ratio) SE
Glass
Ionomer Total
Resin-Based
Total Weight
Odds Ratio
IV, Random, 95% CI
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: z = 1.34 (P = .18)
0.32 (0.06-1.71)
Heterogeneity: Not applicable
Test for overall effect: z = 1.45 (P = .15)
3.2.2 No caries
Subtotal (95% CI) 0.41 (0.12-1.37)
Barja-Fidalgo and Colleagues,31 2009
Haznedaroglu and Colleagues,39 2016 0.41 (0.12-1.37)–0.897
–1.152
0.619
0.862 0.32 (0.06-1.71)
Heterogeneity: τ2 = 0.00; χ21 = 0.06, P = .81; I
2 = 0%
Test for overall effect: z = 1.96 (P = .05)
Test for subgroup differences: χ21 = 0.06, P = .81; I
2 = 0%
Total (95% CI)
21
40
40
21
61
28
56
56
28
84
34.0%
66.0%
66.0%
34.0%
100.0% 0.37 (0.14-1.00)
Favors
glass ionomer
Favors
resin-based
0.01 0.1 1 10 100
eFigure 8. Forest plot of comparison. 3. Overall: Glass ionomer sealants versus resin-based sealants, outcome: 3.2 Caries incidence (4-7 years).
CI: Confidence interval. IV: Inverse-variance. SE: Standard error.
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3.4.1 Carious or deep fissures
Study or Subgroup Log (Odds Ratio) SE
Glass
Ionomer Total
Resin-Based
Total Weight
Odds Ratio
IV, Random, 95% CI
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: z = 8.17 (P < .00001)
1,282
Heterogeneity: τ2 = 4.81; χ28 = 234.52, P < .00001; I
2 = 97%
Test for overall effect: z = 2.26 (P = .02)
3.4.2 No caries
Subtotal (95% CI) 1,445
Chen and Colleagues,33,41 2012 
Guler and Yilmaz,36 2013 68
Arrow and Riordan,30 1995 412
Antonson and Colleagues,29 2012 27
Pardi and Colleagues,38 2005 97
Dhar and Chen,35 2012 50
Haznedaroglu and Colleagues,39 2016 64
Amin,28 2008 24
Chen and Liu,34 2013 75
Baseggio and Colleagues,32 2010 628
–0.687
0.419
0.446
0.511
1.145
1.54
2.692
3.345
6.394
0.915
0.586
0.165
0.956
0.375
0.454
0.384
0.661
1.453
0.377
0.112 1,282
Heterogeneity: τ2 = 2.39; χ29 = 238.55, P < .00001; I
2 = 96%
Test for overall effect: z = 3.10 (P = .002)
Test for subgroup differences: χ21 = 1.11, P = .29; I
2 = 9.5%
Total (95% CI) 2,727
452
1,562
66
412
27
182
50
68
54
75
628
452
2,014
11.4%
88.6%
10.0%
11.4%
8.3%
10.8%
10.6%
10.8%
9.7%
6.1%
10.8%
11.4%
100.0%
Odds Ratio
IV, Random, 95% CI
2.50 (2.00-3.11)
5.62
0.50
1.52
1.56
1.67
3.14
4.66
14.76
28.36
598.24
(1.26-25.07)
(0.16-1.59)
(1.10-2.10)
(0.24-10.17)
(0.80-3.48)
(1.29-7.65)
(2.20-9.90)
(4.04-53.92)
(1.64-489.23)
(285.74-1,252.51)
2.50 (2.00-3.11)
5.06 (1.81-14.13)
Favors
glass ionomer
Favors
resin-based
0.01 0.1 1 10 100
eFigure 9. Forest plot of comparison. 3. Overall: Glass ionomer sealants versus resin-based sealants, outcome: 3.4 Lack of retention (2-3 years).
CI: Confidence interval. IV: Inverse-variance. SE: Standard error.
Odds Ratio
IV, Random, 95% CIStudy or Subgroup Log (Odds Ratio) SE
Glass
Ionomer Total
Resin-Based
Total Weight
Odds Ratio
IV, Random, 95% CI
3.5.2 No caries
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: z = 3.15 (P = .002) 
7.97 (2.19-29.01)
Heterogeneity: Not applicable
Test for overall effect: z = 0.99 (P = .32)
3.5.1 Mixed
Subtotal (95% CI) 0.56 (0.18-1.76)
Barja-Fidalgo and Colleagues,31 2009 –0.575 0.56 (0.18-1.76)
Haznedaroglu and Colleagues,39 2016 2.076
0.583
0.659 7.97 (2.19-29.01)
Heterogeneity: τ2 = 3.13; χ21 = 9.08, P = .003; I
2 = 89%
Test for overall effect: z = 0.55 (P = .58)
Test for subgroup differences:  χ21 = 9.08, P = .003; I
2 = 89%
Total (95% CI)
40
21
21
40
61
56
28
28
56
84
50.7%
50.7%
49.3%
49.3%
100.0% 2.08 (0.15-27.95)
Favors 
glass ionomer
Favors
resin-based
0.01 0.1 1 10 100
eFigure 10. Forest plot of comparison: 3. Overall: Glass ionomer sealants versus resin-based sealants, outcome: 3.5 Lack of retention (4-7 years).
CI: Confidence interval. IV: Inverse-variance. SE: Standard error.
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Odds Ratio
IV, Random, 95% CI
4.1.1 Carious or deep fissures
Study or Subgroup Log (Odds Ratio) SE GI Total
Resin-Modified
GI Total Weight
Odds Ratio
IV, Random, 95% CI
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
4.1.3 Mixed
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
Heterogeneity: Not applicable
Test for overall effect: z = 0.88 (P = .38)
4.1.2 No caries
Subtotal (95% CI) 1.41 (0.65-3.07)
Pereira and Colleagues,24 2003 0.347 0.396 1.41 (0.65-3.07)
Heterogeneity: Not applicable
Test for overall effect: z = 0.88 (P = .38)
Test for subgroup differences: Not applicable
Total (95% CI)
0
0
172
172
172
0
0
172
172
172
100.0%
100.0%
100.0% 1.41 (0.65-3.07)
Favors GI Favors
resin-modified GI
0.01 0.1 1 10 100
eFigure 11. Forest plot of comparison. 4. Glass ionomer sealants versus resin-modified glass ionomer sealants, outcome: 4.1 Caries incidence
(2-3 years). CI: Confidence interval. GI: Glass ionomer. IV: Inverse-variance. SE: Standard error.
Study or Subgroup Log (Odds Ratio) SE GI Total
Resin-Modified
GI Total Weight
Odds Ratio
IV, Random, 95% CI
Odds Ratio
IV, Random, 95% CI
Pereira and Colleagues,24 2003 1.166 0.276 172 172 100.0% 3.21 (1.87-5.51)
Heterogeneity: Not applicable
Test for overall effect: z = 4.22 (P < .0001)
Total (95% CI) 172 172 100.0% 3.21 (1.87-5.51)
Favors GI Favors 
resin-modified GI
0.01 0.1 1 10 100
eFigure 12. Forest plot of comparison. 4. Glass ionomer sealants versus resin-modified glass ionomer sealants, outcome: 4.4 Lack of retention
(2-3 years). CI: Confidence interval. GI: Glass ionomer. IV: Inverse-variance. SE: Standard error.
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Odds Ratio
IV, Random, 95% CI
5.1.1 Carious or deep fissures
Study or Subgroup Log (Odds Ratio) SE
Resin-Modified
GI Total
Polyacid-Modified
Resin Total Weight
Odds Ratio
IV, Random, 95% CI
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
5.1.3 Mixed
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
Heterogeneity: Not applicable
Test for overall effect: z = 1.13 (P = .26)
5.1.2 No caries
Subtotal (95% CI) 0.44 (0.11-1.82)
Pardi and Colleagues,38 2005 –0.817 0.722 0.44 (0.11-1.82)
Heterogeneity: Not applicable
Test for overall effect: z = 1.13 (P = .26)
Test for subgroup differences: Not applicable
Total (95% CI)
0
0
97
97
97
0
0
89
89
89
100.0%
100.0%
100.0% 0.44 (0.11-1.82)
Favors
resin-modified GI
Favors
polyacid-modified
0.01 0.1 1 10 100
eFigure 13. Forest plot of comparison. 5. Resin-modified glass ionomer sealants versus polyacid-modified resin sealants, outcome: 5.1 Caries
incidence (2-3 years). CI: Confidence interval. GI: Glass ionomer. IV: Inverse-variance. SE: Standard error.
Odds Ratio
IV, Random, 95% CI
5.2.1 Carious or deep fissures
Study or Subgroup Log (Odds Ratio) SE
Resin-Modified
GI Total Weight
Odds Ratio
IV, Random, 95% CI
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
5.2.3 Mixed
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
Heterogeneity: Not applicable
Test for overall effect: z = 0.38 (P = .70)
5.2.2 No caries
Subtotal (95% CI) 100.0% 1.17 (0.52-2.66)
Pardi and Colleagues,38 2005 0.16 0.418 100.0% 1.17 (0.52-2.66)
Heterogeneity: Not applicable
Test for overall effect: z = 0.38 (P = .70)
Test for subgroup differences: Not applicable
Total (95% CI)
0
0
97
97
97
0
0
89
89
89 100.0% 1.17 (0.52-2.66)
Favors
resin-modified GI
Favors
polyacid-modified
0.01 0.1 1 10 100
 Polyacid-Modified
Resin Total
eFigure 14. Forest plot of comparison. 5. Resin-modified glass ionomer sealants versus polyacid-modified resin sealants, outcome: 5.2 Lack of
retention (2-3 years). CI: Confidence interval. GI: Glass ionomer. IV: Inverse-variance. SE: Standard error.
ORIGINAL CONTRIBUTIONS
645.e9 JADA 147(8) http://jada.ada.org August 2016
Odds Ratio
IV, Random, 95% CI
6.1.1 Carious or deep fissures
Study or Subgroup Log (Odds Ratio) SE
Polyacid-Modified
Resin Total
Resin-Based
Total Weight
Odds Ratio
IV, Random, 95% CI
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
6.1.3 Mixed
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Not estimable
Heterogeneity: τ2 = 0.00; χ21 = 0.73, P = .39; I
2 = 0%
Test for overall effect: z = 0.03 (P = .97)
6.1.2 No caries
Subtotal (95% CI) 1.01 (0.48-2.14)
Gungor and Colleagues,37 2004 0.81 (0.32-2.01)
Pardi and Colleagues,38 2005
–0.216
0.475
0.466
0.663 1.61 (0.44-5.90)
Heterogeneity: τ2 = 0.00; χ21 = 0.73, P = .39; I
2 = 0%
Test for overall effect: z = 0.03 (P = .97)
Test for subgroup differences: Not applicable
Total (95% CI)
0
0
159
70
89
159
0
0
163
70
93
163
100.0%
66.9%
33.1%
100.0% 1.01 (0.48-2.14)
Favors 
polyacid-modified
Favors
resin-based
0.01 0.1 1 10 100
eFigure 15. Forest plot of comparison. 6. Polyacid-modified resin sealants versus resin-based sealants, outcome: 6.1 Caries incidence (2-3 years).
CI: Confidence interval. IV: Inverse-variance. SE: Standard error.
Odds Ratio
IV, Random, 95% CI
Odds Ratio
IV, Random, 95% CI
Polyacid-Modified
Resin TotalSEStudy or Subgroup
6.2.1 Carious or deep fissures
Not estimableSubtotal (95% CI)
Log (Odds Ratio)
Resin-Based
Total Weight
Heterogeneity: Not applicable
Test for overall effect: Not applicable
6.2.2 No caries
6.2.3 Mixed
0.87 (0.12-6.21)Total (95% CI)
Not estimableSubtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Not applicable
Gungor and Colleagues,37 2004 –1.192 0.30 (0.08-1.17)
Subtotal (95% CI) 0.87 (0.12-6.21)
0.815
0.689
0.523Pardi and Colleagues,38 2005
0
159
0
70
159
89
0
163
0
70
163
93
100.0%
47.5%
100.0%
52.5% 2.26 (0.81-6.30)
Heterogeneity: τ2 = 1.64; χ21 = 5.38, P = .02; I
2 = 81%
Test for overall effect: z = 0.14 (P = .89)
Heterogeneity: τ2 = 1.64; χ21 = 5.38, P = .02; I
2 = 81%
Test for overall effect: z = 0.14 (P = .89)
Test for subgroup differences: Not applicable
0.01 0.1 10 1001
Favors
polyacid-modified 
Favors
resin-based
eFigure 16. Forest plot of comparison. 6. Polyacid-modified resin sealants versus resin-based sealants, outcome: 6.2 Lack of retention (2-3 years).
CI: Confidence interval. IV: Inverse-variance. SE: Standard error.
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eTABLE 1
Evidence profile: sealants compared with fluoride varnishes in pit-and-fissure
occlusal surfaces in children and adolescents.*
QUALITY ASSESSMENT
No. of Studies Study Design Risk of Bias Inconsistency Indirectness Imprecision Other Considerations
Caries incidence (follow-up: range 2-3 y)‡
3 Randomized trials Serious§ Serious¶ Not serious Not serious None
Caries incidence (follow-up: range 4-7 y)**
2 Randomized trials Serious§ Serious†† Not serious Not serious None
Caries incidence (follow-up: range 7 y or more)
1 Randomized trials Very serious§ Not serious Not serious Not serious None
Lack of retention (follow-up: range 2-3 y)
2 Randomized trials Serious§ Not serious Not serious Not serious None
* Sources: Bravo and colleagues,20 Liu and colleagues,22 and Houpt and colleagues.27
† The percentages (30% and 70%) indicate the control group baseline risk (caries prevalence).
‡ A subgroup effect was identified for this outcome (P ¼ .04). Patients who were caries-free (odds ratio, 0.19; 95% confidence interval, 0.07-0.47) and
mixed population (odds ratio, 0.66; 95% confidence interval, 0.30-1.44).
§ Most studies were classified as unclear for the “allocation concealment” and “masking” domains.
¶ Unexplained heterogeneity (P ¼ .0002, I2 ¼ 88%).
# 2 of 3 studies reported being conducted in water-fluoridated communities.
** The studies only reported the outcome in patients who were caries-free.
†† Unexplained heterogeneity (P ¼ .03, I2 ¼ 80%).
‡‡ 2 of 2 studies reported being conducted in water-fluoridated communities.
§§ The study reported being conducted in water-fluoridated communities.
ORIGINAL CONTRIBUTIONS
645.e11 JADA 147(8) http://jada.ada.org August 2016
eTABLE 1 (CONTINUED)
PATIENTS (N) EFFECT QUALITY IMPORTANCE
Sealants Fluoride Varnishes† Relative Odds Ratio
(95% Confidence
Interval)
Absolute (95% Confidence Interval)
66/855 (7.7%) 364/860 (42.3%)# 0.27 (0.11-0.69) 258 fewer per 1,000 (87-349 fewer) Low Critical
30.0% 196 fewer per 1,000 (72-255 fewer)
70.0% 313 fewer per 1,000 (83-496 fewer)
46/228 (20.2%) 131/244 (53.7%)‡‡ 0.19 (0.07-0.51) 356 fewer per 1,000 (165-462 fewer) Low Critical
30.0% 225 fewer per 1,000 (121-271 fewer)
70.0% 393 fewer per 1,000 (157-560 fewer)
30/113 (26.5%) 72/129 (55.8%)§§ 0.29 (0.17-0.49) 290 fewer per 1,000 (176-381 fewer) Low Critical
30.0% 189 fewer per 1,000 (126-232 fewer)
70.0% 296 fewer per 1,000 (167-416 fewer)
Including all sealant material types and tooth preparation techniques, 55.6% of sealants were fully retained at 2
y, and 59.3% were fully or partially retained at 2 y; at 3 y, 56.4% of all sealants were fully retained, and 58.8%
were fully or partially retained at 3 y
Moderate Important
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eTABLE 2
Evidence profile: glass ionomer sealants compared with resin-modified glass
ionomer sealants in pit-and-fissure occlusal surfaces in children and adolescents.*
QUALITY ASSESSMENT
No. of Studies Study Design Risk of Bias Inconsistency Indirectness Imprecision Other
Considerations
Caries incidence (follow-up: range 2-3 y)‡
1 Randomized trials Serious§ Not serious Not serious Very serious¶ None
Caries incidence (follow-up: range 4-7 y)—not reported
—** — — — — — —
Caries incidence (follow-up: range 7 y or more)—not reported
— — — — — — —
Lack of retention (follow-up: range 2-3 y)
1 Randomized trials Serious§ Not serious Not serious Not serious None
Lack of retention (follow-up: range 4-7 y)—not reported
— — — — — — —
Lack of retention (follow-up: range 7 y or more)—not reported
— — — — — — —
* Source: Pereira and colleages.24
† The percentages (30% and 70%) indicate the control group baseline risk (caries prevalence).
‡ Only 1 study reported this outcome. No subgroup analysis was included.
§ All domains were classified as unclear, including the “allocation concealment” and “masking” domains.
¶ The 95% confidence interval suggests an appreciable benefit and an appreciable harm (95% confidence interval, 45% reduction-207% increase for
caries incidence).
# The study was conducted in water-fluoridated communities.
** Dashes indicate data not available.
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eTABLE 2 (CONTINUED)
PATIENTS (N) EFFECT QUALITY IMPORTANCE
Glass Ionomer
Sealants
Resin-Modified
Glass Ionomer
Sealants†
Relative Odds Ratio
(95% Confidence
Interval)
Absolute (95% Confidence
Interval)
27/172 (15.7%) 20/172 (11.6%)# 1.41 (0.65-3.07) 40 more per 1,000 (37 fewer-171 more) Very low Critical
30.0% 77 more per 1,000 (82 fewer-268 more)
70.0% 67 more per 1,000 (97 fewer-178 more)
— — — — — Critical
— — — — — Critical
149/172 (86.6%) 115/172 (66.9%) 3.21 (1.87-5.51) 198 more per 1,000 (122-249 more) Moderate Important
— — — — — Important
— — — — — Important
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eTABLE 3
Evidence profile: resin-modified glass ionomer sealants compared with
polyacid-modified resin sealants in pit-and-fissure occlusal surfaces in children
and adolescents.*
QUALITY ASSESSMENT
No. of Studies Study Design Risk of Bias Inconsistency Indirectness Imprecision Other
Considerations
Caries incidence (follow-up: range 2-3 y)‡
1 Randomized trials Serious§ Not serious Not serious Very serious¶ None
Caries incidence (follow-up: range 4-7 y)—not reported
—** — — — — — —
Caries incidence (follow-up: range 7 y or more)—not reported
— — — — — — —
Lack of retention (follow-up: range 2-3 y)
1 Randomized trials Serious§ Not serious Not serious Very serious†† None
Lack of retention (follow-up: range 4-7 y)—not reported
— — — — — — —
Lack of retention (follow-up: range 7 y or more)—not reported
— — — — — — —
* Source: Pardi and colleagues.38
† The percentages (30% and 70%) indicate the control group baseline risk (caries prevalence).
‡ Only 1 study reported this outcome. No subgroup analysis was conducted.
§ All risk of bias domains were classified as unclear.
¶ 95% confidence interval suggests a large benefit and a large harm (95% confidence interval, 89% reduction-82% increase). Only 9 events are
informing this outcome.
# The study was conducted in water-fluoridated communities.
** Dashes indicate data not available.
†† 95% confidence interval suggests a large benefit and a large harm (95% confidence interval, 48% reduction-166% increase). Only 27 events are
informing this outcome.
ORIGINAL CONTRIBUTIONS
645.e15 JADA 147(8) http://jada.ada.org August 2016
eTABLE 3 (CONTINUED)
PATIENTS (N) EFFECT QUALITY IMPORTANCE
Resin-Modified
Glass Ionomer
Sealants
Polyacid-Modified
Resin Sealants†
Relative Odds Ratio
(95% Confidence
Interval)
Absolute (95%
Confidence Interval)
3/97 (3.1%) 6/89 (6.7%)# 0.44 (0.11-1.82) 37 fewer per 1,000 (49 more-60 fewer) Very low Critical
30.0% 141 fewer per 1,000 (138 more-255 fewer)
70.0% 193 fewer per 1,000 (109 more-496 fewer)
— — — — —
— — — — —
15/97 (15.5%) 12/89 (13.5%) 1.17 (0.52-2.66) 19 more per 1,000 (60 fewer-158 more) Very low Important
— — — — —
— — — — —
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eTABLE 4
Evidence profile: polyacid-modified resin sealants compared with resin-based
sealants in pit-and-fissure occlusal surfaces in children and adolescents.*
QUALITY ASSESSMENT
No. of Studies Study Design Risk of Bias Inconsistency Indirectness Imprecision Other Considerations
Caries incidence (follow-up: range 2-3 y)‡
2 Randomized trials Serious§ Not serious Not serious Very serious¶ None
Caries incidence (follow-up: range 4-7 y)—not reported
—** — — — — — —
Caries incidence (follow-up: range 7 y or more)—not reported
— — — — — — —
Lack of retention (follow-up: range 2-3 y)
2 Randomized trials Serious§ Serious†† Not serious Serious‡‡ None
Lack of retention (follow-up: range 4-7 y)—not reported
— — — — — — —
Lack of retention (follow-up: range 7 y or more)—not reported
— — — — — — —
* Sources: Gungor and colleagues37 and Pardi and colleagues.38
† The percentages (30% and 70%) indicate the control group baseline risk (caries prevalence).
‡ The studies only reported the outcome in patients who were caries-free. No subgroup analysis was conducted.
§ The 2 studies were classified as “unclear” risk of bias for the domain “allocation concealment.”
¶ 95% confidence interval suggests a large benefit and a large harm (95% confidence interval, 52% reduction-114% increase).
# 1 of 2 studies reported being conducted in water-fluoridated communities.
** Dashes indicate data not available.
†† Unexplained heterogeneity (P < .00001, I2 ¼ 97%).
‡‡ 95% confidence interval suggests a large benefit and a large harm (95% confidence interval, 88% reduction-521% increase).
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eTABLE 4 (CONTINUED)
PATIENTS (N) EFFECT QUALITY IMPORTANCE
Polyacid-Modified
Resin Sealants
Resin-Based
Sealants†
Relative Odds Ratio
(95% Confidence
Interval)
Absolute (95%
Confidence Interval)
16/159 (10.1%) 16/163 (9.8%)# 1.01 (0.48 to 2.14) 1 more per 1,000 (49 fewer-91 more) Very low Critical
30.0% 2 more per 1,000 (129 fewer-178 more)
70.0% 2 more per 1,000 (133 more-172 fewer)
— — — — —
— — — — —
15/159 (9.4%) 15/163 (9.2%) 0.87 (0.12-6.21) 11 fewer per 1,000 (80 fewer-294 more) Very low Important
— — — — —
— — — — —
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